Public map story

Cristin Milioti · Bright Mosaic

Around the world today: News pulse 2026-08-26 · The Guardian: The U.S. Food and Drug Administration approves the daraxonrasib drug as a treatment for metastatic pancreatic cancer, making it the first RAS inhibitor drug to be approved for the disease. This came after a previous study showed that it nearly doubled the survival rate for patients compared to chemotherapy. A perspective from Kyiv.

announcement · Charlotte, US · 0 likes · 2 replies